Add BrightSurf on Google Email

University of California - San Diego


Slow road to a synapse

A study led by Subhojit Roy reveals how certain proteins in neurons travel at a slower pace than others, assembling into larger complexes that move down the axon. The proposed model suggests a 'plume' of proteins, where complexes disassemble and reassemble as they progress, making the overall motion slow and coordinated.

Tiny talk on a barnacle's back

Researchers at UC San Diego and Scripps Institute of Oceanography used matrix-assisted laser desorption ionization mass spectrometry to reveal multiplex microbial interactions. The technique allowed them to see competition for resources, secretion of molecules altering neighboring organisms' phenotypes.

SourceUniversity of California - San Diego·JournalAngewandte Chemie·DateMay 10, 2011

Study finds Filipino children in San Diego County at higher risk for Kawasaki disease

A study by researchers at UC San Diego finds that Filipino children are more likely to develop aneurysms and inflammation of the blood vessels of the heart compared to other Asian and non-Asian backgrounds. The research highlights the need for medical providers to be aware of Kawasaki disease in high-risk populations.

SourceUniversity of California - San Diego·JournalThe Pediatric Infectious Disease Journal·DateMay 6, 2011

Scientists create stable, self-renewing neural stem cells

Researchers at University of California - San Diego School of Medicine and colleagues report a game-changing advance in stem cell science: the creation of long-term, self-renewing neural precursor cells from human embryonic stem cells that can be directed to become many types of neuron. The new process promises to have broad applicatio...

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateApr 25, 2011

A cancer marker and treatment in 1?

Researchers at UC San Diego School of Medicine have discovered a potential cancer biomarker in non-human sialic acid antibodies, which can also be used as a treatment to suppress tumor growth. The study found that patients with carcinomas have elevated levels of antibodies to one specific Neu5Gc-containing sugar chain.

SourceUniversity of California - San Diego·JournalCancer Research·DateApr 19, 2011

Vision loss in eye disease slowed using novel encapsulated cell therapy

A phase 2 clinical trial demonstrates the benefit of a neurotrophic factor to treat geographic atrophy, a severe form of age-related macular degeneration. The therapy, which delivers ciliary neurotrophic factor using encapsulated cell therapy, slowed vision loss and stabilized vision in patients with high-dose treatment.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateApr 6, 2011

Call of the riled

Researchers discovered that cancer cells generate a 'stress response' signal that induces nearby macrophages to issue a similar stress response, promoting inflammation and tumor development. This finding presents a potential target for tumor-specific therapies.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateApr 4, 2011

Primordial soup gets spicier

Researchers have reanalyzed Stanley Miller's 1958 'primordial soup' samples and found a diverse array of organic compounds, including sulfur amino acids. The discovery supports the hypothesis that volcanoes and lightning played a key role in creating the building blocks of life on Earth.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateMar 21, 2011

Searching for the soul of the genome

Researchers at the University of California, San Diego, develop novel method to detect long-distance chromosomal interactions and find association with CAD risk from altered inflammatory signaling response. The study identifies 33 regulatory elements in the 9p21 interval involved in cellular signaling and response to inflammation.

The hitch in the drug? The itch in the drug

Researchers identify two distinct neuronal signaling pathways activated by Imiquimod, a topical cream that treats skin diseases while inducing severe itching as a side effect. The study may lead to designing future drugs that effectively treat targeted conditions while blocking problematic itching and scratching.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateFeb 8, 2011